GUANGZHOU, China, Nov. 8, 2024 /PRNewswire/ -- At the 136th Canton Fair's industry trends forum, focused on the development trends of overseas markets for kitchenware and tableware products, the "2024 Overseas Market Trend Report on Kitchenware and Tableware Products" was unveiled, offering an extensive analysis of the current and projected trends within the global kitchenware and tableware industry.
The report underscores China's leading role in exporting steel, ceramic, and glass kitchenware and tableware. With robust production capabilities and cost-effective manufacturing, China holds a significant competitive edge in these sectors. In 2023, China's global export share for steel, ceramic, and glass kitchenware and tableware reached 67%, 66%, and 49%, respectively.
Despite China's dominance, the report highlights a diverse competitive landscape in the global market. European countries such as Germany, France, and Italy continue to exert considerable influence in high-end markets with their exceptional design and quality standards.
On the import front, the United States stands as the largest importer of kitchenware and tableware worldwide. In 2023, the U.S. accounted for 26%, 17%, and 11% of global imports in steel, ceramic, and glass kitchenware and tableware, respectively. Additionally, European countries including Spain, Germany, France, the United Kingdom, and Italy are significant importers, reflecting a sustained demand for high-quality products. Saudi Arabia also shows notable market demand for ceramic and glass kitchenware and tableware imports.
During the forum, Liang Junjiao, Creative Director of Yangjiang Chuan Ye Art Design Co., Ltd., emphasized the importance of design innovation and product viability, asserting that continuous product innovation and R&D are crucial for companies to stand out in the global market.
Ma Xiaoyan, General Manager of Guangdong Xiangshun Kitchenware Co., Ltd., discussed transitioning from a foreign trade factory to a brand-focused company. She highlighted the importance of high-quality products, a long-term brand vision, and understanding market trends for international expansion and sustainable growth.
The Canton Fair, renowned not only as a platform for international trade but also as a hub for information exchange and idea generation, has been hosting industry forums since 2010. By leveraging its extensive expertise across various sectors, the fair continues to provide important market insights for companies within the industry, helping them better understand market dynamics and the competitive landscape.
The 137th Canton Fair will be held from April 15 to May 5, 2025 in Guangzhou. For more information, please visit https://www.cantonfair.org.cn/en-US
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Global Kitchenware and Tableware Market Trends Unveiled at the 136th Canton Fair Industry Forum
FREMONT, Calif., Dec. 6, 2024 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce its commercial presence in the Asia Pacific (APAC) region with the installation of the ARGOâ„¢ HT System, an advanced ultra-sensitive proteomics platform, at the prestigious Hong Kong Center for Neurodegenerative Diseases (HKCeND). The ARGO HT System along with the NULISAâ„¢ Platform are designed to revolutionize biomarker discovery by enabling researchers to detect and quantify proteins at unprecedented levels of sensitivity and accuracy.
"Expansion of the ARGO HT installed base to the APAC region represents a significant step forward in our vision to bring transformative proteomics solutions to researchers worldwide," said Dr. Yuling Luo, Founder, Chairman and CEO of Alamar Biosciences. "We are excited to contribute to HKCeND's vibrant scientific community and support groundbreaking advancements in the fight against neurodegenerative diseases."
Prof. Nancy Ip, the Director of Hong Kong Center for Neurodegenerative Diseases (HKCeND), added, "The integration of the NULISA Technology enabled by the ARGO HT System into our research infrastructure is a game-changer. This technology will allow us to explore the proteomic underpinnings of neurodegenerative diseases in ways that were previously unimaginable."
The partnership with HKCeND will focus on unlocking new insights into the molecular mechanisms of neurodegenerative diseases such as Alzheimer's disease, and Parkinson's disease. The ARGO HT System and NULISA Platform deployments will empower HKCeND's researchers to identify novel biomarkers, accelerate drug development, and improve early detection and personalized treatment strategies for patients.
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of disease. The company's proprietary NULISA Platform along with the ARGO HT System work seamlessly with the latest advances in genomics to achieve single digit attomolar detection sensitivity, greatly surpassing the most sensitive protein detection technology on the market today. For more information, please visit alamarbio.com.
About Hong Kong Center for Neurodegenerative Diseases
The Hong Kong Center for Neurodegenerative Diseases (HKCeND) is a leading research institution dedicated to advancing the understanding and treatment of neurodegenerative disorders. By fostering interdisciplinary collaborations and leveraging state-of-the-art technologies, HKCeND aims to make transformative contributions to global neuroscience.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO HT Install at Hong Kong Center for Neurodegenerative Diseases
Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO HT Install at Hong Kong Center for Neurodegenerative Diseases
Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO HT Install at Hong Kong Center for Neurodegenerative Diseases
